findmyKOL
Clinical trialNCT00032006CompletedPhase 2Interventional

Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer

SponsorAlliance for Clinical Trials in OncologyEnrollment48Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Drugs such as goserelin, leuprolide, flutamide, or bicalutamide may stop the adrenal glands from producing androgens. Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Combining hormone therapy with internal radiation may be effective in treating locally recurrent prostate cancer. PURPOSE: Phase II trial to study the effectiveness of hormone therapy followed by internal radiation in treating patients who have locally recurrent prostate cancer following external-beam radiation therapy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ccop - Scottsdale Oncology Program

    Scottsdale, Arizona, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Ccop - Carle Cancer Center

    Urbana, Illinois, United States

  • Ccop - Iowa Oncology Research Association

    Des Moines, Iowa, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Ccop - Missouri Valley Cancer Consortium

    Omaha, Nebraska, United States

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania, United States

  • Ccop - St. Vincent Hospital Cancer Center, Green Bay

    Green Bay, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2002
Primary completion
31 Oct 2003
Completion
31 Oct 2003
Last update posted
13 Jul 2016
Registered enrollment
48
Registry id
NCT00032006
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.